drugset / Trial / NCT04682860

Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

NCT04682860

Phase 4 Completed 50 enrolled Ankara City Hospital Bilkent
RandomizedParallel-groupDouble-blindTreatment

Summary

One of the most common complaints of admission to the emergency room is gastroenteritis. One of the most common complaints in acute gastroenteritis is abdominal pain. The aim of our study is to investigate whether hyoscine butylbromide used within the indication has an effect on abdominal pain due to acute gastroenteritis. The main purpose of our study is to reduce the pain of the patient at 30th and 60th minutes compared to 0th minute.

Timeline

Start
2021-09-08
Primary completion
2021-12-03
Completion
2022-01-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyoscine butylbromide Unknown 20 mg Intravenous

Indications